The NYSE's Securities Information Processor (SIP), which consolidates quote and trade data for NYSE-listed stocks, went down Thursday.» Read More
Stocks tanked out of the gate after disappointing U.S. data, but then quickly rebounded as traders saw a buying opportunity.
Stocks sank after a triple whammy of disappointing U.S. data, signaling that third quarter growth figures could be revised lower.
Hedge funds are getting hit hard this year as oil falls. Many of these funds are positioned long the U.S. market and growth stocks.
*Deutsche Telekom shares down 0.7 percent. FRANKFURT, Oct 14- Deutsche Telekom had already given up on trying to sell its near 67 percent stake in T-Mobile US before upstart French telecoms firm Iliad dropped its bid on Monday and is now looking to avoid having to stump up more funds for the U.S. mobile network operator, analysts and investors said.
Weakness in stocks is distracting from economic tailwinds: lower oil prices, a better U.S. economy, and high cash levels at U.S. corporations.
Traders are looking for an oversold bounce after Ebola concerns and growth worries have pushed the S&P down 7 percent from its record.
Market internals have deteriorated dramatically, which may indicate its time for a bounce.
There's starting to be lots of push back on initial public offerings. Investors want to make money rather than just spend it.
Shale stocks are tanking amid two crude realities: oil prices at multi-year lows and the way drilling is financed.
The options market is betting on a 30 percent rally in one airline.
For all of you who thought speed trading began 10 years ago, think again. It started long ago.
The S&P 500 Index is at a two-month low. How real is the main concern of slowing global growth?
Canada- based Tekmira Pharmaceuticals, which is said to be furthest along among the companies working on a treatment, and Chimerix Inc, whose experimental oral antiviral drug was used on the first U.S. victim of the disease, have seen a huge increase in trading activity in their stock options. On Wednesday, shares of Chimerix fell more than 18 percent in 40 minutes...
Markets are facing the collision between a slowdown in global growth (ex-U.S.) and the Fed debate on when it should raise interest rates.
Stocks close at the day's lows as worries about growth outside of the U.S. and fears the Fed may raise rates soon weigh.
As less original research is done, companies have increasingly learned how to play the "game" of lowering estimates going into the quarter.
Traders are also watching Brazil after its election surprise.
The big money isn't rushing to buy insurance against a crash, despite a range of products that promise to help.
Stocks surge on Goldilocks scenario. Markets benefiting from an economy that's not too hot, not too cold.
The jobs report had some healthy numbers, but is it enough to convince the Federal Reserve to hike rates sooner rather than later?